Showing results (61-70 of 315) with videos related to
Sort By:
Pageof 32
Gastroenterology Clinics of North America|January 5, 2002
Gastrointestinal safety of COX-2 specific inhibitorsC J Hawkey, J I JonesGut|November 1, 1989
Effect of information leaflets on knowledge in patients with gastrointestinal diseasesG M Hawkey, C J HawkeyPostgraduate Medical Journal|May 1, 1983
The need for prophylactic treatment to the central nervous system in patients with aggressive non-Hodgkin's lymphomaC J Hawkey, P J ToghillGut|March 1, 1983
Inhibition of prostaglandin synthetase in human rectal mucosaC J Hawkey, M Lo CastoProstaglandins, Leukotrienes, and Medicine|September 1, 1983
A thromboxane synthetase inhibitor in Raynaud's phenomenonE W Jones, C J HawkeyExpert Opinion on Investigational Drugs|July 5, 2005
Gastrointestinal effects of COX-2 inhibitorsL M Jackson, C J HawkeyClinical Nutrition (Edinburgh, Scotland)|February 1, 1992
Therapeutic approaches to the problem of biliary sludge and gallstone formation during total parenteral nutritionF E Murray, C J HawkeyGut|October 1, 1988
Medical treatment of ulcerative colitis: scoring the advancesC J Hawkey, A B HawthorneEuropean Journal of Gastroenterology & Hepatology|February 12, 1998
Specific mediator-directed therapy for gastrointestinal diseasesW A Stack, C J HawkeyBest Practice & Research. Clinical Gastroenterology|February 28, 2002
Physiology and organ-related pathology of the elderly: stomach ulcersJ I Jones, C J HawkeyPageof 32